Literature DB >> 25056196

Pyridoxine-induced sensory ataxic neuronopathy and neuropathy: revisited.

Kongkiat Kulkantrakorn1.   

Abstract

High dose pyridoxine is neurotoxic. Previous case reports were sparse and little is known about the clinical and electrodiagnostic findings. Three patients with pyridoxine-induced sensory ataxic neuropathy were studied and a review of the involved literature was performed. Three patients, aged 80, 83 and 83 years old, presented with sensory ataxia for 3-8 months. Examination showed signs of polyneuropathy and sensory ataxia. Six hundred milligrams of pyridoxine was consumed each day for 3-10 years, in the form of vitamin B1-6-12 combination tablet. Investigations for other causes of neuropathy were unremarkable. Blood levels of vitamin B6 were markedly elevated at 104.6, 81.4 and 66.9 times of upper normal limits. Electrodiagnostic tests showed symmetric axonal sensory polyneuropathy in two patients. Two years after vitamin discontinuation, all patients showed no significant improvement in the neuropathy and gait. In conclusion, consumption of high dose pyridoxine can cause sensory neuronopathy and axonal sensorimotor polyneuropathy, leading to sensory ataxia which may not be reversible.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056196     DOI: 10.1007/s10072-014-1902-6

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

Review 1.  Peripheral neuropathy: pathogenic mechanisms and alternative therapies.

Authors:  Kathleen A Head
Journal:  Altern Med Rev       Date:  2006-12

2.  Pyridoxine (vitamin B6) toxicity: enhancement by uremia in rats.

Authors:  S Levine; A Saltzman
Journal:  Food Chem Toxicol       Date:  2002-10       Impact factor: 6.023

Review 3.  Non-nutritional uses of vitamin B6.

Authors:  D A Bender
Journal:  Br J Nutr       Date:  1999-01       Impact factor: 3.718

4.  Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity.

Authors:  A R Berger; H H Schaumburg; C Schroeder; S Apfel; R Reynolds
Journal:  Neurology       Date:  1992-07       Impact factor: 9.910

5.  Pyridoxine (vitamin B6) neurotoxicity: enhancement by protein-deficient diet.

Authors:  Seymour Levine; Arthur Saltzman
Journal:  J Appl Toxicol       Date:  2004 Nov-Dec       Impact factor: 3.446

6.  Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.

Authors:  H Schaumburg; J Kaplan; A Windebank; N Vick; S Rasmus; D Pleasure; M J Brown
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

7.  Differential vulnerability of 3 rapidly conducting somatosensory pathways in the dog with vitamin B6 neuropathy.

Authors:  U Schaeppi; G Krinke
Journal:  Agents Actions       Date:  1985-09

8.  The pattern and diagnostic criteria of sensory neuronopathy: a case-control study.

Authors:  Jean-Philippe Camdessanché; Guillemette Jousserand; Karine Ferraud; Christophe Vial; Philippe Petiot; Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Brain       Date:  2009-06-08       Impact factor: 13.501

9.  Pyridoxine induced neuropathy by subcutaneous administration in dogs.

Authors:  Jin-Young Chung; Jung-Hoon Choi; Cheol-Yong Hwang; Hwa-Young Youn
Journal:  J Vet Sci       Date:  2008-06       Impact factor: 1.672

  9 in total
  6 in total

1.  Regressive pyridoxine-induced sensory neuronopathy in a patient with homocystinuria.

Authors:  Andoni Echaniz-Laguna; Rachel Mourot-Cottet; Esther Noel; Jean-Baptiste Chanson
Journal:  BMJ Case Rep       Date:  2018-06-28

Review 2.  Integrative Medicine for Gastrointestinal Disease.

Authors:  Michelle L Dossett; Ezra M Cohen; Jonah Cohen
Journal:  Prim Care       Date:  2017-06       Impact factor: 2.907

Review 3.  Sensory Neuronopathies.

Authors:  Allison Crowell; Kelly G Gwathmey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-23       Impact factor: 5.081

Review 4.  Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases.

Authors:  Florence van Hunsel; Sonja van de Koppel; Eugène van Puijenbroek; Agnes Kant
Journal:  Drug Saf       Date:  2018-09       Impact factor: 5.606

5.  Association of Serum Pyridoxal Phosphate Levels with Established Status Epilepticus.

Authors:  Clio Rubinos; Maria Jose Bruzzone; Courtney Blodgett; Carolyn Tsai; Puja Patel; Rachel Hianik; Rakesh Jadav; Jordane Boudesseul; Chuning Liu; Hongtu Zhu; Susan E Wilson; Casey Olm-Shipman; Rick Meeker; Lawrence J Hirsch
Journal:  Neurocrit Care       Date:  2022-09-07       Impact factor: 3.532

Review 6.  Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment.

Authors:  Alfredo Córdova-Martínez; Alberto Caballero-García; Daniel Pérez-Valdecantos; Enrique Roche; David César Noriega-González
Journal:  Biomedicines       Date:  2022-05-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.